Article info

PDF

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012

Authors

  • Jennifer E Miller NYU Langone Medical Center, NYU School of Medicine, Bioethics International, New York, New York, USA PubMed articlesGoogle scholar articles
  • David Korn Edmond J. Safra Center for Ethics, Harvard University, Massachusetts General Hospital, Harvard Medical School, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Joseph S Ross Section of General Internal Medicine and the Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA Center for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven, Connecticut, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jennifer E Miller; jennifer.miller{at}nyumc.org
View Full Text

Citation

Miller JE, Korn D, Ross JS
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012

Publication history

  • Received 19 August 2015
  • Revised 14 October 2015
  • Accepted 16 October 2015
  • Published in print 1 November 2015.
  • Published online 12 November 2015.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.